Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
EBIT Margin

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   EBIT Margin(%) 14.0415.2615.44-18.9611.60

What is the latest EBIT Margin ratio of NATH BIOGENES (INDIA) ?

The latest EBIT Margin ratio of NATH BIOGENES (INDIA) is 14.04 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.04
Mar202415.26
Mar202315.44
Mar2022-18.96
Mar201311.60

How is EBIT Margin of NATH BIOGENES (INDIA) Trending?

Years EBIT Margin % Change
Mar2025 14.04
-7.99
Mar2024 15.26
-1.17
Mar2023 15.44
Positive
Mar2022 -18.96
Negative
Mar2013 11.6 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare EBIT Margin ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹324.4 Cr -4.1% -6.3% -25.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,243.9 Cr -3.8% -9.9% -28.9% Stock Analytics
KAVERI SEED COMPANY ₹5,978.5 Cr -0.2% 4.5% 10.1% Stock Analytics
VENKYS (INDIA) ₹2,060.8 Cr -2.7% -3.5% -36.2% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,513.7 Cr 4% 3.2% -26.9% Stock Analytics
INDO US BIOTECH ₹298.6 Cr -1.4% -7.7% -45.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4.1%

-6.3%

-25.9%

SENSEX

-2.7%

-1.3%

-2.3%


You may also like the below Video Courses